We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+5.65%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.31B
AUM Growth
+$72.1M
Cap. Flow
-$212M
Cap. Flow %
-6.41%
Top 10 Hldgs %
31.06%
Holding
111
New
31
Increased
21
Reduced
21
Closed
33

Top Buys

Rank Stock Value
1
AET
Aetna Inc
AET
+$92.4M
2
BIIB icon
Biogen
BIIB
+$88.4M
3
BAX icon
Baxter International
BAX
+$59.5M
4
DISH
DISH Network Corp.
DISH
+$58.6M
5
META icon
Meta Platforms (Facebook)
META
+$53.6M

Top Sells

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$110M
2
AAPL icon
Apple
AAPL
+$94.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$94M
4
LRCX icon
Lam Research
LRCX
+$90.7M
5
AGN
Allergan plc
AGN
+$84.2M

Sector Composition

Rank Sector Weight
1 Healthcare 38.8%
2 Technology 9.31%
3 Communication Services 4.67%
4 Energy 3.99%
5 Financials 3.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
PUT
Merck
MRK
$312B
$138M 4.16%
+2,506,921
New +$133M
BMY icon
2
CALL
Bristol-Myers Squibb
BMY
$124B
$135M 4.06%
1,830,300
+2,300
+0.1% +$163K
AET
3
DELISTED
Aetna Inc
AET
$112M 3.39%
918,724
+804,493
+704% +$92.4M
EW icon
4
Edwards Lifesciences
EW
$48.9B
$110M 3.32%
3,305,103
+398,082
+14% +$13.6M
ALDR
5
DELISTED
Alder Biopharmaceuticals
ALDR
$97.4M 2.94%
3,899,209
+356,562
+10% +$9.65M
META icon
6
Meta Platforms (Facebook)
META
$1.63T
$92M 2.78%
805,179
+465,321
+137% +$53.6M
AMAT icon
7
Applied Materials
AMAT
$448B
$90.5M 2.73%
3,777,487
+2,203,108
+140% +$48.6M
MDCO
8
DELISTED
Medicines Co
MDCO
$88.1M 2.66%
2,618,754
+392,547
+18% +$13.8M
LLY icon
9
PUT
Eli Lilly
LLY
$1.05T
$85.8M 2.59%
+1,089,700
New +$82M
BIIB icon
10
Biogen
BIIB
$29.5B
$81.1M 2.45%
+335,290
New +$88.4M
XLV icon
11
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$41.5B
$74.3M 2.24%
+1,035,900
New +$73M
JAZZ icon
12
Jazz Pharmaceuticals
JAZZ
$15.3B
$72.1M 2.17%
509,981
-254,403
-33% -$37.5M
WBA
13
DELISTED
Walgreens Boots Alliance
WBA
$69.3M 2.09%
832,187
-367,131
-31% -$29.6M
ABBV icon
14
AbbVie
ABBV
$452B
$66.1M 2%
1,079,626
-1,316,702
-55% -$80.2M
AMZN icon
15
Amazon
AMZN
$2.66T
$64.1M 1.94%
1,792,480
-760,800
-30% -$25.7M
DISH
16
DELISTED
DISH Network Corp.
DISH
$62.8M 1.9%
+1,198,731
New +$58.6M
BAX icon
17
Baxter International
BAX
$11.5B
$61.3M 1.85%
+1,356,543
New +$59.5M
HRTX icon
18
Heron Therapeutics
HRTX
$90.3M
$60.5M 1.82%
3,351,104
+277,634
+9% +$5.42M
AMAT icon
19
CALL
Applied Materials
AMAT
$448B
$57.8M 1.74%
+2,409,300
New +$53.1M
QQQ icon
20
CALL
Invesco QQQ Trust
QQQ
$471B
$56.7M 1.71%
+527,600
New +$57M
CRUS icon
21
Cirrus Logic
CRUS
$6.9B
$53M 1.6%
1,366,079
+1,098,706
+411% +$39.4M
MSFT icon
22
Microsoft
MSFT
$2.95T
$52.5M 1.58%
1,026,566
-340,537
-25% -$17.7M
MCK icon
23
McKesson
MCK
$97.3B
$52.5M 1.58%
+281,238
New +$49.3M
UNH icon
24
UnitedHealth
UNH
$396B
$51.8M 1.56%
+367,047
New +$48.9M
HCA icon
25
HCA Healthcare
HCA
$82.8B
$49.5M 1.49%
642,873
-1,395,315
-68% -$110M
1
2 3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
CPRC
Consolidated Portfolio Review Corp Woodbury, New York $1.1B AUM 8.96% 1-Year Est. Return
AWP
Abacus Wealth Partners Santa Monica, California $1.1B AUM 14.74% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return

PFM Health Sciences's Q2 2016 Portfolio in Review

As of Q2 2016, PFM Health Sciences held 111 positions worth $3.31B, up 2.2% from $3.24B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

PFM Health Sciences withdrew a net $212M in Q2 2016, closing 33 positions and reducing 21 holdings. Its most notable exit was Lam Research, an estimated $90.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 45% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Biogen worth $81.1M.

  • PFM Health Sciences's largest Q2 2016 buy was Biogen: 335,290 shares worth $81.1M.
  • PFM Health Sciences added most to Aetna Inc in Q2 2016, an estimated $92.4M increase.
  • PFM Health Sciences's biggest Q2 2016 reduction was HCA Healthcare, cutting an estimated $110M.
  • PFM Health Sciences fully exited Lam Research in Q2 2016, selling an estimated $90.7M.
  • PFM Health Sciences's ten largest holdings make up 31% of its $3.31B portfolio in Q2 2016.
  • PFM Health Sciences opened 31 new positions and closed 33 in Q2 2016.
  • PFM Health Sciences's portfolio value rose 2.2% quarter-over-quarter to $3.31B.

Based on PFM Health Sciences's 13F filing for Q2 2016, filed 15 Aug 2016.